Learn
In the Media
What is Cannabinol (CBN)? Four things to know about this rare cannabinoid.
What is cannabinol, or CBN? View this infographic to learn four things about cannabinol. Is CBN psychoactive? How is CBN different from THC and CBD?...
InMed Shares Preclinical Data at 2020 EB World Congress
At the EB World Congress in London, UK, InMed's scientific team officially revealed CBN as the active pharmaceutical ingredient (API) in INM-755 while exhibiting preclinical...
Maxim Jacobs Interviews Eric A. Adams about InMed’s Programs Using Cannabinol CBN
In this episode of Edison Talks, Maxim Jacobs, Edison’s director of research for North America, has an in-depth discussion with Eric A. Adams, the CEO...
InMed CEO says ‘tremendous potential’ for its cannabinoid-based therapy to treat glaucoma
InMed Pharmaceuticals Inc (CSE:IN) (OTCMKTS:IMLFF) CEO Eric Adams sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. In this interview,...
Source: Proactive Investors
Edison Talks: Interview with Eric Adams, CEO of InMed Pharmaceuticals
In the first episode of Edison Talks, Maxim Jacobs, Edison’s director of research for North America, discusses InMed’s biosynthesis platform and its pipeline of cannabinoids...
CEO interview: InMed Biosynthesis for Cannabinoid Manufacturing
In this interview, Eric Adams, chief executive officer of InMed Pharmaceuticals provides an overview of InMed’s differentiated biosynthesis platform and its therapeutic pipeline of cannabinoids....
Source: Edison Group